The new Lockdown Craze sweeping the globe. Welcome to our viewers on pbs in america and around the globe. Major trials of a new vaccine have shown its effective against some new variants of covid 19, helping to reduce fears that they might prove resistant. Novavax is an american jab but its being produced in the uk. Its also easier to roll out than some previous vaccines since it doesnt need to be kept at ultra low temperatures. The news came amid a deepening row between another vaccine maker, astrazeneca, and the European Union over shortages. Our medical editor fergus walsh reports. Once again, science has triumphed in the fight against coronavirus. The Us Firm Novavax has released results of its british trial showing the first proven efficacy against the new, more contagious uk variant. There were more than 15,000 volunteers on the trail throughout the uk. Over half the cases of covid recorded were the result of the new variant. The results showed the vaccine was 95 effective agains
believe they had the legal ability to do 24 hours ago quite a turn of events. i have never heard anything like that where the president said i am not sure if the courts w let this through. thanks to you, phil. more covid news now. the new york times tonight quoting several sources saying the fda aims for sful approval of pfizer s covid vaccine by labor day. also, new york s mayor, new york city s mayor announced the city will soon require proof of the covid vaccine for indoor dining, entertaining and gyms. in san francisco people vaccinated with the one-shot johnson & johnson vaccine will now be able to get a supplemental dose of the pfizer, moderna mrna vaccine. new york times quotes several sources as saying the fda aims for full approval of pfizer s vaccine by labor day. and in maine a different kind of response to covid in the delta surge. unlike the two measures we told
COVID-19 Update
As the first vaccine doses are administered for COVID-19, there is light at the end of the tunnel
Print edition : January 15, 2021
T+
T-
Members of staff deliver injections of the Pfizer-BioNTech vaccine to invited patients at a drive-in vaccination centre in Greater Manchester of northwest England on December 17. Photo: OLI SCARFF/AFP
British Prime Minister Boris Johnson leaving 10 Downing Street after it was announced that the United Kingdom government had approved the Pfizer/BioNTech Covid vaccine for use, on December 2. Photo: Peter Summers/Getty Images
Construction work in full swing for a COVID vaccine storage unit at the Rajiv Gandhi Super Speciality Hospital in New Delhi, on December 20, 2020. Photo: R.V. Moorthy